March 27, 2015 22:02 (IST)
Strides Arcolab on announced launch of the generic version of Hepatitis C drug 'Sofosbuvir' under the brand name 'Virso'.
March 27, 2015 18:23 (IST)
Two different types of antibiotic injections manufactured by India's Emcure Pharmaceuticals sold in the US by Heritage Pharmaceuticals Inc are being recalled following concerns over quality control processes.
March 26, 2015 16:01 (IST)
German generics drug maker Stada struck an alliance with family-owned Hetero Drugs Ltd of India to gain access to active ingredients for cancer drugs, Stada said on Thursday.
March 25, 2015 23:56 (IST)
The Supreme Court on Wednesday stayed till April 28 the order of Delhi High Court barring Indian pharmaceuticals major Glenmark from making, marketing or selling its anti-diabetes medicines in which US drug major Merck Sharp and Dohme (MSD) has claimed a patent right.
March 25, 2015 18:29 (IST)
The availability of product in other markets is subject to approvals from the regulatory authorities in respective countries, Cipla said.
March 25, 2015 16:05 (IST)
Sun Pharmaceutical Industries Ltd, India's largest drug maker by sales, said on Wednesday that its $3.2-billion (Rs 19,840 crore at 1 dollar = 62 rupees) acquisition of smaller rival Ranbaxy Laboratories Ltd will not restrict it from making further large acquisitions.
March 24, 2015 20:19 (IST)
It further said the approvals received from the respective High Courts have been filed by Ranbaxy and Sun Pharma with the respective Registrar of Companies today.
March 24, 2015 16:07 (IST)
Sun Pharmaceutical Industries has received approval from the Reserve Bank of India (RBI) for transfer of overseas investments of Ranbaxy to it and issue its shares to the non-resident shareholders of the latter as part of the $4-billion merger deal between the companies.
March 24, 2015 16:01 (IST)
Aarti Drugs on Tuesday said its two manufacturing facilities have received import alert from the US Food and Drug Administration, a development which could impact the company's exports to the American market.
March 23, 2015 20:20 (IST)
Under the proposed deal, Shasun will amalgamate with Strides in an all-stock transaction.
March 23, 2015 19:52 (IST)
In an order issued today, CCI also approved the deal with Emcure, which would purchase the 'divestment products'.
March 23, 2015 18:31 (IST)
Earlier this month, Natco Pharma launched the drug in Nepal.
March 20, 2015 21:48 (IST)
Chemicals and Fertilisers Minister Ananth Kumar on Friday said there should be a dedicated ministry for the pharmaceuticals sector to end policy fragmentation due to various departments come under different ministries.
March 20, 2015 17:57 (IST)
The court also set aside its single-judge's April 5, 2013 order refusing to restrain Indian company from manufacturing and selling its medicines meant for treatment of Type-2 diabetes.
March 19, 2015 20:00 (IST)
Medicines are set to become cheaper as the National Pharmaceutical Pricing Authority (NPPA) has directed drug makers to pass on benefits of lower excise duty to consumers.
March 19, 2015 13:45 (IST)
Lupin currently holds 14 per cent market share for Celebrex and expect $58 million sales from the drug with a 15 per cent market share.
March 18, 2015 22:32 (IST)
With many major Indian drug makers coming under more intense scrutiny from it, the US Food and Drug Administration (FDA) on Wednesday said it has not singled out domestic manufacturers and that the increased number of inspections here is a reflection of increasing size of the country's pharmaceutical industry.
March 18, 2015 17:46 (IST)
Drug maker Wockhardt Ltd on Wednesday said the US Food and Drug Administration (FDA) has not found any issues with respect to data security and control measures at Chikalthana plant in a recent inspection, but suggested continuous voluntary compliance for "desired quality culture".
March 15, 2015 14:14 (IST)
The National Pharmaceutical Pricing Authority (NPPA) is still to recover Rs 3,680.43 crore from various pharmaceutical companies for overcharging, while almost 95 per cent of the amount is under litigation.
March 10, 2015 16:26 (IST)
Dr Reddy's had cash and market investments worth $456 million, according to a company presentation in February.